Examkin

Soru

Zorluk: OrtaDepressive Disorders

A 58-year-old woman is evaluated in the psychiatric clinic for a severe depressive episode characterized by profound sadness, anhedonia, early morning awakening, and significant weight loss. Over the course of the following year, her major depressive disorder proves difficult to manage, requiring a progressive escalation of her treatment plan due to varying degrees of treatment resistance. Her course ultimately culminates in a severe decompensation requiring urgent intervention. Arrange the following therapeutic steps in the most appropriate chronological sequence according to standard evidence-based treatment algorithms for major depressive disorder, from her initial presentation to the management of her final life-threatening deterioration.

  1. 1Initiation of an oral selective serotonin reuptake inhibitor (SSRI) at a standard starting dose.
  2. 2Dose titration of the prescribed SSRI to its maximum tolerated and efficacious limit after noting only a partial clinical response at a 4-week follow-up.
  3. 3Augmentation of the treatment regimen with an atypical antipsychotic after an 8-week trial of the maximized SSRI fails to achieve full remission.
  4. 4Inpatient admission and preparation for electroconvulsive therapy (ECT) following the sudden onset of mood-congruent delusions and severe food refusal.

Cevap

The correct chronological sequence for escalating treatment in major depressive disorder is: 1) Initiation of an SSRI at a standard dose, 2) Dose titration of the SSRI following a partial response, 3) Augmentation with an atypical antipsychotic after non-remission on a maximized dose, and 4) Electroconvulsive therapy (ECT) upon the development of severe psychotic features and food refusal.
The standard treatment algorithm for major depressive disorder begins with monotherapy using a first-line agent (SSRI, SNRI, bupropion, or mirtazapine). If the patient exhibits a partial response after an adequate trial (typically 4-6 weeks), the initial step is dose optimization. If the patient continues to experience significant residual symptoms despite an optimized dose, augmentation with another agent (such as an atypical antipsychotic) or switching to a different antidepressant class is indicated. Finally, for severe major depressive disorder complicated by life-threatening features (such as refusal to eat, acute active suicidality, or psychotic features), urgent electroconvulsive therapy (ECT) is the treatment of choice.

Adım Adım Çözüm

1
Identify the initial presentation of uncomplicated major depressive disorder.
The first step is initiating a first-line agent, such as an SSRI.
SSRIs are standard first-line therapies due to their favorable side-effect profiles and established efficacy.
2
Evaluate the management of a partial clinical response after an initial 4-week trial.
The next step is to maximize the dose of the current SSRI.
Dose optimization is the standard protocol when a patient shows partial improvement and tolerates the medication well, before switching or augmenting.
3
Determine the strategy for treatment-resistant depression when the maximized SSRI fails to achieve remission.
The subsequent step is augmentation with another agent, such as an atypical antipsychotic.
Augmentation or switching classes is indicated when an adequate trial of a maximized first-line agent remains ineffective.
4
Recognize the emergence of life-threatening and psychotic features.
The final step in this sequence is inpatient admission for ECT.
ECT is the gold-standard, rapid-acting treatment for depression complicated by mood-congruent delusions and severe food refusal.

Anahtar Kavram

Stepped-care pharmacological management and indications for electroconvulsive therapy (ECT) in major depressive disorder.
Bu soruyu puanla

Konular

Depressive Disorders

Bu konudan daha fazla soru